Is Spravato Right For You? Who May Qualify For Treatment?

Is Spravato right for you? When depression does not improve enough with traditional treatment, it can feel frustrating, exhausting, and discouraging. For some adults, Spravato® may be an option worth discussing with a qualified mental health provider.

Spravato is a prescription nasal spray used in specific clinical situations for depression. It is given only in a certified healthcare setting under supervision, with monitoring before patients leave the clinic. If you have been wondering whether Spravato may be right for treatment-resistant depression, this guide explains the basics, who may be a candidate, and what to expect before starting treatment.

Calm supervised Spravato treatment room in a professional mental health clinic — Spravato treatment is administered in a supervised clinical setting with required monitoring.

What Is Treatment-Resistant Depression?

Treatment-resistant depression generally refers to depression that has not improved enough after trying appropriate antidepressant treatments. This does not mean there is no hope. It means your care team may need to evaluate other options, adjust your treatment plan, or consider therapies designed for people who have not responded adequately to standard approaches.

Every patient’s history is different. Diagnosis, previous medications, length of treatment, side effects, other health conditions, and current symptoms all matter when deciding what may be appropriate next. If you are still exploring care options, Wholesome Clinic also offers support for depression treatment in Frisco, TX.

What Is Spravato?

Spravato is the brand name for esketamine, a prescription nasal spray that works differently from many traditional antidepressants. It is used for certain adults with treatment-resistant depression and may also be used in specific situations involving depressive symptoms with acute suicidal thoughts or behavior, when clinically appropriate.

Spravato is not a take-home medication. Because it can cause side effects such as sleepiness, dizziness, dissociation, changes in blood pressure, or impaired coordination, treatment must take place in a certified medical setting with observation afterward. For additional patient education, visit our Spravato FAQs.

Who May Be a Candidate for Spravato?

A person may be evaluated for Spravato if they are an adult with depression that has not responded adequately to previous treatment. However, eligibility depends on a clinical assessment. A provider will review your mental health history, medication history, current symptoms, medical conditions, and safety considerations before recommending treatment.

Spravato may be worth discussing if:

You have tried antidepressant medication and still have significant depressive symptoms.
Your depression continues to affect daily life, work, relationships, or motivation.
You are looking for a supervised treatment option guided by trained clinicians.
You are willing and able to attend in-office treatment sessions and monitoring visits.

Spravato is not right for everyone. Certain medical conditions, medications, substance use history, blood pressure concerns, pregnancy considerations, or other factors may affect whether it is appropriate. That is why a consultation is an important first step.

What Makes Spravato Different From Traditional Antidepressants?

Many traditional antidepressants affect serotonin, norepinephrine, or dopamine pathways. Spravato works through a different pathway involving glutamate activity in the brain. For some patients with treatment-resistant depression, this different mechanism is one reason a provider may consider it as part of a broader treatment plan.

Spravato is often used along with an oral antidepressant, depending on the patient’s diagnosis and treatment plan. Your provider can explain how it may fit with your current medications and whether adjustments are needed.

What to Expect Before Starting Spravato

Before treatment begins, your care team will typically complete a detailed evaluation. This helps determine whether Spravato is clinically appropriate and whether it can be used safely.

Clinical consultation: You will discuss your symptoms, depression history, past treatments, and goals.
Medication review: Your provider will review current and past medications, including antidepressants and other prescriptions.
Medical screening: Blood pressure, health history, and safety considerations may be reviewed.
Treatment expectations: The team will explain visit length, monitoring, transportation requirements, and possible side effects.
Care planning: If appropriate, your provider will outline a schedule and follow-up plan.

What Happens During a Spravato Treatment Visit?

During a Spravato appointment, the medication is self-administered as a nasal spray under clinical supervision. Afterward, patients remain in the clinic for observation. The monitoring period is important because Spravato can temporarily affect alertness, perception, blood pressure, and coordination.

Patients should not drive themselves home after treatment. Your clinic team will review transportation requirements and any instructions for the rest of the day.

Questions to Ask at Your Spravato Consultation

Am I a candidate for Spravato based on my depression history?
How does Spravato fit with my current treatment plan?
What side effects should I understand before starting?
How often are treatments scheduled?
How will we measure progress?
What should I arrange for transportation after each visit?

When to Seek Immediate Help

If you are experiencing thoughts of self-harm, feel unable to stay safe, or are worried someone may be in immediate danger, seek emergency help right away. Call local emergency services or contact a crisis hotline immediately. You can also reach the 988 Suicide & Crisis Lifeline for immediate crisis support in the United States. Spravato consultations are not a replacement for emergency mental health care.